Senior Principal Scientist
Bristol-Myers Squibb Company
Cambridge, Massachusetts
Nanda has approximately 10 years of experience in molecular biology, immunoassay, and bioanalysis. At BMS, he serves as the bioanalytical lead, providing support for CAR-T, gene therapy, and biologics. Before joining BMS, Nanda held the role of bioanalytical scientist at Alexion, Pfizer, and AstraZeneca, where he had increasing responsibilities in supporting oligonucleotide therapeutics, gene therapy, and biologics. He actively participates in various working groups and has authored publications related to bioanalysis for gene therapy and CAR-T, among other topics.
Disclosure information not submitted.
A Case Study in Cell Therapy Persistence by ddPCR
Wednesday, May 15, 2024
10:30 AM – 10:40 AM PT
Wednesday, May 15, 2024
10:40 AM – 11:00 AM PT